WHO ICTRP trial

High-Grade Atrioventricular CONDUCTion Block After Transcatheter Aortic Valve…

ACTRN12621001700820 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12621001700820
Public title High-Grade Atrioventricular CONDUCTion Block After Transcatheter Aortic Valve Implantation (CONDUCT TAVI)
Scientific title Prospective observational study on the accuracy of predictors of high-grade atrioventricular CONDUCTion block after Transcatheter Aortic Valve Implantation (CONDUCT TAVI)
Primary sponsor Royal North Shore Hospital, Northern Sydney Local Health District
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries Australia
Conditions High grade atrioventricular block;Transcatheter Aortic Valve Implantation;Permanent pacemaker; High grade atrioventricular block Transcatheter Aortic Valve Implantation Permanent pacemaker;Cardiovascular - Other cardiovascular diseases
Interventions This study will investigate the factors associated with high grade atrioventricular block (HGAVB) occurring up to 24 months after Transcatheter Aortic Valve Implantation (TAVI). Electrophysiology testing (including AV Wenckebach and HV…
Registration date Dec 13, 2021
Target size 205
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations